Invenomic Capital Management’s Vontier VNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,396
Closed -$1.32M 183
2025
Q4
$1.32M Buy
+35,396
New +$1.35M 0.06% 140
2023
Q4
Sell
-480,895
Closed -$14.9M 201
2023
Q3
$14.9M Buy
480,895
+13,193
+3% +$406K 0.62% 53
2023
Q2
$15.1M Sell
467,702
-858,897
-65% -$24.8M 0.76% 42
2023
Q1
$36.3M Buy
1,326,599
+33,681
+3% +$814K 2.05% 14
2022
Q4
$25M Buy
1,292,918
+319,565
+33% +$5.99M 1.7% 15
2022
Q3
$16.3M Buy
+973,353
New +$21.7M 1.4% 24

Other funds holding VNT

Invenomic Capital Management's VNT Position: Q1 2026 in Review

Invenomic Capital Management sold out of Vontier (VNT) in Q1 2026, closing a stake of 35,396 shares — an estimated $1.32M sold.

Invenomic Capital Management first reported a position in VNT in Q3 2022 and held it in 6 quarters. The position peaked at $36.3M in Q1 2023. 486 funds tracked by Wall St. Rank hold VNT as of Q1 2026.

  • Invenomic Capital Management reported no remaining Vontier position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 35,396 Vontier shares in Q1 2026, an estimated $1.32M.
  • Invenomic Capital Management first reported a position in Vontier in Q3 2022 and held it in 6 quarters.
  • Invenomic Capital Management's Vontier position peaked at $36.3M in Q1 2023.
  • 486 funds tracked by Wall St. Rank held Vontier as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.